Lipocine, Inc. (LPCN)
1.54
+0.01
(+0.65%)
USD |
NASDAQ |
Nov 06, 10:12
Lipocine Total Liabilities (Quarterly) : 2.068M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.068M |
| March 31, 2026 | 2.528M |
| December 31, 2025 | 2.528M |
| September 30, 2025 | 1.931M |
| June 30, 2025 | 1.449M |
| March 31, 2025 | 1.300M |
| December 31, 2024 | 1.513M |
| September 30, 2024 | 1.581M |
| June 30, 2024 | 1.824M |
| March 31, 2024 | 1.490M |
| December 31, 2023 | 2.632M |
| September 30, 2023 | 2.271M |
| June 30, 2023 | 1.931M |
| March 31, 2023 | 2.062M |
| December 31, 2022 | 1.908M |
| September 30, 2022 | 1.775M |
| June 30, 2022 | 2.304M |
| March 31, 2022 | 5.194M |
| December 31, 2021 | 6.912M |
| September 30, 2021 | 7.578M |
| June 30, 2021 | 11.43M |
| March 31, 2021 | 8.186M |
| December 31, 2020 | 10.01M |
| September 30, 2020 | 10.24M |
| June 30, 2020 | 10.40M |
| Date | Value |
|---|---|
| March 31, 2020 | 14.44M |
| December 31, 2019 | 13.37M |
| September 30, 2019 | 9.837M |
| June 30, 2019 | 9.827M |
| March 31, 2019 | 10.44M |
| December 31, 2018 | 11.42M |
| September 30, 2018 | 10.92M |
| June 30, 2018 | 11.42M |
| March 31, 2018 | 15.01M |
| December 31, 2017 | 6.345M |
| September 30, 2017 | 2.484M |
| June 30, 2017 | 2.900M |
| March 31, 2017 | 2.345M |
| December 31, 2016 | 1.326M |
| September 30, 2016 | 1.572M |
| June 30, 2016 | 2.585M |
| March 31, 2016 | 2.994M |
| December 31, 2015 | 3.392M |
| September 30, 2015 | 2.179M |
| June 30, 2015 | 1.665M |
| March 31, 2015 | 1.337M |
| December 31, 2014 | 1.634M |
| September 30, 2014 | 2.057M |
| June 30, 2014 | 1.670M |
| March 31, 2014 | 1.50M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 115.90B |
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 200.29M |
| Veru, Inc. | 8.651M |
| Eli Lilly & Co. | 107.80B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.84M |
| Shareholders Equity (Quarterly) | 21.77M |
| Current Ratio | 11.48 |